| Literature DB >> 30063823 |
Shinya Tashiro1,2, Jose M M Caaveiro1,2,3, Makoto Nakakido1,2, Aki Tanabe1, Satoru Nagatoishi1,2, Yasushi Tamura4, Noriyuki Matsuda5, Dali Liu6, Quyen Q Hoang, Kouhei Tsumoto1,2,7.
Abstract
DJ-1 is a Parkinson's disease associated protein endowed with enzymatic, redox sensing, regulatory, chaperoning, and neuroprotective activities. Although DJ-1 has been vigorously studied for the past decade and a half, its exact role in the progression of the disease remains uncertain. In addition, little is known about the spatiotemporal regulation of DJ-1, or the biochemical basis explaining its numerous biological functions. Progress has been hampered by the lack of inhibitors with precisely known mechanisms of action. Herein, we have employed biophysical methodologies and X-ray crystallography to identify and to optimize a family of compounds inactivating the critical Cys106 residue of human DJ-1. We demonstrate these compounds are potent inhibitors of various activities of DJ-1 in vitro and in cell-based assays. This study reports a new family of DJ-1 inhibitors with a defined mechanism of action, and contributes toward the understanding of the biological function of DJ-1.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30063823 PMCID: PMC6370461 DOI: 10.1021/acschembio.8b00701
Source DB: PubMed Journal: ACS Chem Biol ISSN: 1554-8929 Impact factor: 5.100